A case of refractory chronic respiratory tract infection due to Pseudomonas aeruginosa successfully controlled by combination of clarithromycin and azithromycin

Intern Med. 2012;51(11):1383-6. doi: 10.2169/internalmedicine.51.6985. Epub 2012 Jun 1.

Abstract

The prognosis of patients with chronic respiratory tract infections, especially diffuse panbronchiolitis, is remarkably improved by long-term administration of low-dose macrolides. However, in some cases, patients are refractory to macrolide treatment and show a low or no response; therefore, new treatment strategies are required. Here we present a patient refractory to either single low-dose clarithromycin or azithromycin but responded remarkably to the combination usage of both macrolides.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Azithromycin / administration & dosage*
  • Clarithromycin / administration & dosage*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunologic Factors / administration & dosage
  • Middle Aged
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas aeruginosa*
  • Respiratory Tract Infections / drug therapy*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Immunologic Factors
  • Azithromycin
  • Clarithromycin